Resources with keywords: covid-19
Emphasizes this guidance is specific to SARS-CoV-2 and does not apply to other Corona Viruses
P Bager, et al.
An observational study comparing the severity of COVID-19 and influenza among nearly 6 million Denmark residents finds a higher rate of hospitalizations and deaths in those infected with SARS-CoV-2—mainly among unvaccinated people, those with chronic conditions, and males—from 2022 to 2024.
This dashboard provides data about COVID-19, flu, RSV and mpox virus levels in wastewater.
CDC endorsing that people 65 years and older and those who are moderately or severely immunocompromised receive a second dose of 2024-2025 COVID-19 vaccine six months after their first dose.
Key Points include strategies for contingency capacity
This guidance applies to all U.S. settings where healthcare is delivered, including nursing homes and home health. The recommendations in this guidance continue to apply after the expiration of the federal COVID-19 Public Health Emergency.
Currently there remains a lack of regulatory alignment among OSHA, the Food and Drug Administration (FDA), and the National Institute for Occupational Safety and Health (NIOSH) regarding respirator approval for use in health care.
This guidance is intended for clinical laboratory and support staff who handle or process specimens associated with COVID-19.
Discusses the disease, prevention via vaccination, signs and symptoms, complications, testing and diagnosis, who is most at risk, etc.
Gillum D, et al.
The US government issued a long-awaited policy update last month intended to better manage the hazards associated with risky biological research.
